24 September 2014, Brussels
On September 24, the COEURE Coordination Action will hold its Opening Conference in Brussels at Diamant Conference Center.
The COoperation on EUropean Research in Economics Coordination Action is intended to bring together the key stakeholders in the European economic research space – scientists, users of research in the policy community or the private sector, and funders of research – in a process of stocktaking, consultation and evaluation in order to propose an Agenda for Research Funding for Economics in Europe. COEURE is financed under the 7th Framework Programme.
The main objectives of COEURE are to evaluate the strengths and weaknesses of the European research in economics and to map the frontiers of economic research, assessing the European contribution to these frontiers and evaluating its potential to contribute to the policy issues on the European 2020 Agenda.
This conference’s objective is to mobilize the community of researchers in economics, decision makers on economic affairs and managers of economic research around COEURE.
For further information and registration, please contact Eunate Mayor, Scientific Communication Policy Adviser of the COEURE project. Email: firstname.lastname@example.org
22-24 September 2014, Łódź, Poland
The event will be held over three days, with presentations delivered by researchers from the international community, including presentations from keynote speakers and state-of-the-art lectures. The conference aims to enable researchers to build connections between different digital applications.
22-24 September 2014, Lodz, Poland
The conference aims to enable researchers to build connections between different digital applications. The event will be held over three days, with presentations delivered by researchers from the international community, including presentations from keynote speakers and state-of-the-art lectures.
23 September 2014, London, UK
The volume of data is exploding, and that is challenging drug makers' ability to transform big data into additional revenue. But companies who can exploit big data and analytics will have the potential to improve their productivity and efficiency, especially in the discovery, research and development of new products, experts say. McKinsey has predicted big data could reduce research and development costs for pharmaceutical makers by $40 billion to $70 billion. They anticipate that data will form the cornerstone of future value-based assessment and also be used for gaining market access, and enhance competitiveness.